173 related articles for article (PubMed ID: 18973656)
21. [Resistance in influenza viruses].
Hungnes O; Dudman SG
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2601-6. PubMed ID: 19023375
[TBL] [Abstract][Full Text] [Related]
22. [Neuraminidase inhibitors in prophylaxis and treatment of influenza].
Nitsch-Osuch A; Brydak LB; Wardyn AK
Pol Merkur Lekarski; 2008 Jul; 25(145):67-73. PubMed ID: 18839619
[TBL] [Abstract][Full Text] [Related]
23. Antivirals and influenza: frequency of resistance.
Monto AS
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
[TBL] [Abstract][Full Text] [Related]
24. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.
Hurt AC; Ho HT; Barr I
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):795-805. PubMed ID: 17140356
[TBL] [Abstract][Full Text] [Related]
25. [The use of antiviral agents during an (impending) influenza pandemic].
Opstelten W; van Steenbergen JE; van Essen GA; Van der Sande MA
Ned Tijdschr Geneeskd; 2007 May; 151(18):1008-12. PubMed ID: 17508684
[TBL] [Abstract][Full Text] [Related]
26. The potential for multidrug-resistant influenza.
van der Vries E; Schutten M; Boucher CA
Curr Opin Infect Dis; 2011 Dec; 24(6):599-604. PubMed ID: 22001947
[TBL] [Abstract][Full Text] [Related]
27. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.
Liu H; Yao X; Wang C; Han J
Mol Pharm; 2010 Jun; 7(3):894-904. PubMed ID: 20420444
[TBL] [Abstract][Full Text] [Related]
28. Drivers and consequences of influenza antiviral resistant-strain emergence in a capacity-constrained pandemic response.
Dafilis MP; Moss R; McVernon J; McCaw J
Epidemics; 2012 Dec; 4(4):219-26. PubMed ID: 23351374
[TBL] [Abstract][Full Text] [Related]
29. Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1).
Uyeki T
N Engl J Med; 2009 Dec; 361(23):e110. PubMed ID: 19923564
[No Abstract] [Full Text] [Related]
30. Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.
Ledesma J; Vicente D; Pozo F; Cilla G; Castro SP; Fernández JS; Ruiz MP; Navarro JM; Galán JC; Fernández M; Reina J; Larrauri A; Cuevas MT; Casas I; Breña PP;
J Clin Virol; 2011 Jul; 51(3):205-8. PubMed ID: 21592854
[TBL] [Abstract][Full Text] [Related]
31. Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.
Nguyen HT; Trujillo AA; Sheu TG; Levine M; Mishin VP; Shaw M; Ades EW; Klimov AI; Fry AM; Gubareva LV
Antiviral Res; 2012 Mar; 93(3):381-6. PubMed ID: 22330888
[TBL] [Abstract][Full Text] [Related]
32. [Research progress of neuraminidase inhibitors for anti-influenza].
Liu AL; Wang HD; Yang F; Du GH
Yao Xue Xue Bao; 2009 Sep; 44(9):935-42. PubMed ID: 20055166
[TBL] [Abstract][Full Text] [Related]
33. Influenza drug resistance.
Pizzorno A; Abed Y; Boivin G
Semin Respir Crit Care Med; 2011 Aug; 32(4):409-22. PubMed ID: 21858746
[TBL] [Abstract][Full Text] [Related]
34. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread.
Handel A; Longini IM; Antia R
PLoS Comput Biol; 2007 Dec; 3(12):e240. PubMed ID: 18069885
[TBL] [Abstract][Full Text] [Related]
35. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.
Baz M; Abed Y; Papenburg J; Bouhy X; Hamelin ME; Boivin G
N Engl J Med; 2009 Dec; 361(23):2296-7. PubMed ID: 19907034
[No Abstract] [Full Text] [Related]
36. [Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination].
Uhnoo I; Linde A
Lakartidningen; 2005 Dec 5-11; 102(49):3802-3, 3805-6, 3808. PubMed ID: 16408704
[TBL] [Abstract][Full Text] [Related]
37. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
[TBL] [Abstract][Full Text] [Related]
38. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
39. Antiviral resistance in influenza viruses: laboratory testing.
Laplante J; St George K
Clin Lab Med; 2014 Jun; 34(2):387-408. PubMed ID: 24856534
[TBL] [Abstract][Full Text] [Related]
40. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.
Lackenby A; Democratis J; Siqueira MM; Zambon MC
Antivir Ther; 2008; 13(6):809-20. PubMed ID: 18839782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
